Sunwin International Neutraceuticals in Distribution Pact with Turkish Company Qufu, China, August 2, 2007 - (Market Wire) - Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the largest producers of the low calorie sweetener (Stevia) in China, announced today it has entered into a distribution agreement with Agra Uluslararasi ticeret Ltd. ("Agra"), a distribution company doing business in the Turkish Nation.
Under the terms of the agreement Sunwin will allow Agra to be the exclusive distributor of its stevia based products as well as certain herb based medicines throughout Turkey. The agreement is part of Sunwin's plan to increase its distribution capabilities on a global basis for its ramping production capacity. Sunwin intends to continue to aggressively seek partners in distribution for various places throughout the world and anticipates reaching similar agreements with other distributors in the coming quarters.
Laiwang Zhang, President and Chairman of Sunwin International Neutraceuticals, commented "We are happy to work with Agra and count them among our growing list of distribution partners. We have focused on building capacity and product depth in our fiscal 2007 year and we now look to capitalize on the growing worldwide demand for our products. This agreement is another step in our global distribution plans."
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN) is an industry leader in agricultural processing, in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. For more info about Sunwin, please visit http://www.sunwin.biz.
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission |